Federal contract receipt

$21,999,907 from Department of Health and Human Services to GENENTECH USA, INC

XOFLUZA (BALOXAVIR MARBOXIL)

Signals

Full and openLarge award

Office of Federal Procurement Policy

Public Spend Intelligence - sledai.com

Award #CONT_AWD_75A50324F80013_7505_36F79723D0219_3600

Signed2024-09-27

PlaceCA

XOFLUZA (BALOXAVIR MARBOXIL)

Total obligated$21,999,906.94

PoP Start

2024-09-30

PoP End

2025-09-29

COMPETED

Awarded on 2024-09-27